%0 Journal Article
%T BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review
%A Anita Shah
%A Jerzy Windyga
%A Johnny N. Mahlangu
%A Lawrence Schwartz
%A Nikki Church
%A Sanjay P. Ahuja
%J Archive of "Therapeutic Advances in Hematology".
%D 2018
%R 10.1177/2040620718777903
%K BAY 81-8973
%K hemophilia A
%K Kovaltry
%K pharmacokinetics
%K prophylaxis
%K recombinant factor VIII
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041863/